Albert Labs International Corp. carries a market capitalization of 372,066.00, placing it among publicly traded companies globally. Its enterprise value stands at 1.47M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 372,066.00 |
| Enterprise Value | 1.47M |
Albert Labs International Corp. currently has 74.41M shares outstanding.
| Shares Outstanding | 74.41M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.81 |
| P/TBV Ratio | -3.30 |
| P/FCF Ratio | -2.75 |
| P/OCF Ratio | -2.86 |
Albert Labs International Corp. maintains a current ratio of 0.03, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -2.29, indicating conservative leverage, while an interest coverage ratio of -15,489.21 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.03 |
| Quick Ratio | 0.00 |
| Debt / Equity | -2.29 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | -15,489.21 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -676.75 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Albert Labs International Corp.'s stock has declined approximately -75% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | -75% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
EBITDA reached -2.32M, while operating income came in at -2.32M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -2.32M |
| Pretax Income | -2.31M |
| Net Income | -2.31M |
| EBITDA | -2.32M |
| EBIT | -2.32M |
| Earnings Per Share (EPS) | -0.03 |
Albert Labs International Corp. holds 111.00 in cash and equivalents against 10,130.00 in total debt, resulting in a net debt position of 10,019.00. Total book value stands at -1.81M, with working capital of -484,737.00 providing operational flexibility.
| Cash & Cash Equivalents | 111.00 |
| Total Debt | 10,130.00 |
| Net Debt | 10,019.00 |
| Equity (Book Value) | -1.81M |
| Book Value Per Share | -0.02 |
| Working Capital | -484,737.00 |
Albert Labs International Corp. produced -512,556.00 in operating cash flow over the past twelve months. After subtracting 20,057.00 in capital expenditures, free cash flow totaled -492,499.00 - equivalent to -0.01 per share.
| Operating Cash Flow | -512,556.00 |
| Capital Expenditures | 20,057.00 |
| Free Cash Flow | -492,499.00 |
| FCF Per Share | -0.01 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -23.26 |
| FCF Yield | -36.39 |
Albert Labs International Corp.'s most recent stock split took place on March 10, 2022 with a 10:1 split ratio.
| Last Split Date | 3/10/2022 |
| Split Ratio | 10:1 |
Albert Labs International Corp. posts an Altman Z-Score of -341.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -341.07 |